Trials / Sponsors / RVAC Medicines (US), Inc.
RVAC Medicines (US), Inc.
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Safety & Immunogenicity of RVM-V001/RVM-V002 or RVMV001+RVMV002 (Co Administered as Separate Injections) in He Infectious Disease, COVID-19 | Phase 1 / Phase 2 | 2023-03-22 |
| Terminated | Safety and Immunogenicity of RVM-V001 in Healthy Individuals Previously Vaccinated With BNT162b2 and mRNA-1273 Infectious Disease, COVID-19 | Phase 1 | 2022-09-12 |